J. Houglum

发表

Pharmacologic considerations in the treatment of injured athletes with nonsteroidal anti-inflammatory drugs.

J. Houglum, 1998, Journal of athletic training.

Quantitative Determination of the α-Amylase Inhibitor from Phaseolus Vulgaris using size Exclusion High-Performance Liquid Chromatography

J. Houglum, G. S. Chappell, 1984 .

Identification of the slow reacting substances from cat paws.

D. Sok, C. Sih, J. Pai, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Principles of pharmacology for athletic trainers

G. Harrelson, D. Leaver-Dunn, J. Houglum, 2005 .

Lack of Tobramycin Distribution into Saliva

G. B. Edwards, J. Houglum, P. Cascella, 1984, Pharmaceutical Research.

Interferon: mechanisms of action and clinical value.

J. Houglum, 1983, Clinical pharmacy.

Steroid Δ4-Reductase Activity in Hepatomas of Different Growth Rates

H. Morris, Y. Abul-Hajj, J. Houglum, 1974 .

Predictors of Academic Success and Failure in a Pharmacy Professional Program

R. Aparasu, J. Houglum, Teresa M. Delfinis, 2005, American Journal of Pharmaceutical Education.

Assay of chlortetracycline in animal feeds by liquid chromatography with fluorescence detection.

A. Knutson, J. Houglum, R. Larson, 1997, Journal of AOAC International.

Asthma medications: basic pharmacology and use in the athlete.

J. Houglum, 2000, Journal of athletic training.

Phenobarbital Stability in Different Dosage Forms: Alternatives for Elixirs

N. Dietz, J. Houglum, G. S. Chappell, 1988, Pharmaceutical Research.